遗传性转甲状腺素蛋白肾淀粉样变的病理谱及临床病理相关性:一项法国观察性研究
该法国观察性研究回顾性纳入30例活检证实的遗传性转甲状腺素蛋白肾淀粉样变患者,比较其淀粉样沉积分布与AL/AA淀粉样变,并分析TTR变异、性别和诊断年龄与临床病理的相关性。结果显示ATTRv患者肾小管间质受累多于AL/AA,V30M患者肾小球沉积更多且eGFR更高。
要点
- 与AL/AA淀粉样变相比,ATTRv肾淀粉样变更常累及肾小管间质。
- V30M患者较非V30M患者肾小球沉积更多且eGFR更高。
- ATTRv肾淀粉样变应被考虑于伴肾功能异常的ATTRv淀粉样变患者及其可能亲属,无论蛋白尿水平如何。
核心结论
- ATTRv肾淀粉样变累及所有肾脏分区,但与AL/AA淀粉样变相比似乎更常累及肾小管间质区。
- V30M患者代表该病的主要表现形式,具有更高的肾小球/小动脉受累风险。
- ATTRv肾淀粉样变应被考虑于伴肾功能异常的ATTRv淀粉样变患者及其可能亲属,无论蛋白尿水平如何。
研究设计与样本
- 回顾性纳入来自两个法国参考中心的30例活检证实的ATTRv肾淀粉样变患者。
- TTR变异类型:V30M(26/30,包括2例多米诺肝移植受者)、S77Y(2/30)、V122I(1/30)和S50R(1/30)。
- 通过比较淀粉样沉积分布与AL或AA淀粉样变患者,并分析TTR变异、性别和诊断年龄与临床病理的相关性。
主要发现
- 与AL和AA淀粉样变相比,ATTRv患者肾小球、小动脉和动脉淀粉样沉积相似,但皮质和髓质肾小管间质受累更多(33%、44%、77%,P = .03)。
- 肾小球沉积的存在与蛋白尿范围相关,但部分肾小球ATTRv淀粉样变丰富的患者无显著蛋白尿。
- V30M患者较非V30M患者肾小球沉积更多(100%和25%,比值比 = 114,95%置信区间 3.85-3395.00,P = .001)。
- V30M患者较非V30M患者估算肾小球滤过率更高[50(四分位距 44-82)和27(四分位距 6-31)mL/min/1.73 m²,P = .004]。
- 未发现淀粉样沉积根据性别或诊断年龄的差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac and neurological involvements are the main clinical features of hereditary transthyretin (ATTRv) amyloidosis. Few data are available about ATTRv amyloid nephropathy (ATTRvN). METHODS: We retrospectively included 30 patients with biopsy-proven ATTRvN [V30M (26/30) including two domino liver recipients, S77Y (2/30), V122I (1/30) and S50R (1/30) variants] from two French reference centers. We described the pathological features by comparing amyloid deposits distribution to patients with AL or AA amyloidosis, and sought to determine clinicopathological correlation with known disease-modifying factors such as TTR variant, gender and age at diagnosis. RESULTS: In comparison with AL and AA amyloidosis, ATTRv patients had similar glomerular, arteriolar and arterial amyloid deposits, but more cortical and medullary tubulointerstitial (33%, 44%, 77%, P = .03) involvement. While the presence of glomerular deposits is associated with the range of proteinuria, some patients with abundant glomerular ATTRv amyloidosis had no significant proteinuria. V30M patients had more glomerular (100% and 25%, odds ratio = 114, 95% confidence interval 3.85-3395.00, P = .001) deposits, and higher estimated glomerular filtration rate [50 (interquartile range 44-82) and 27 (interquartile range 6-31) mL/min/1.73 m², P = .004] than non-V30M patients. We did not find difference in amyloid deposition according to gender or age at diagnosis. CONCLUSION: ATTRvN affects all kidney compartments, but compared with AL/AA amyloidosis, ATTRvN seems to involve more frequently tubulointerstitial areas. V30M patients represents the dominant face of the disease with a higher risk of glomerular/arteriolar involvement. ATTRvN should thus be considered in patients, and potential relatives, with ATTRv amyloidosis and kidney dysfunction, regardless of proteinuria level.
引用
- Dang J, Ferlicot S, Misrahi M, et al. Pathological spectrum of hereditary transthyretin renal amyloidosis and clinicopathologic correlation: a French observational study. Nephrol Dial Transplant. 2023. PMID: 36646436. doi:10.1093/ndt/gfad006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。